Latest News for TLSA
US stock futures were edging towards a flat start early on Thursday morning, as afterhours earnings from Nvidia and Salesforce continued to be digested....
4:15pm: Big earnings due Tech led the way on Wednesday as investors positioned themselves ahead of a wave of major earnings reports. The Nasdaq jumped 1.3%...
3:45pm: Proactive news headlines Tiziana Life Sciences Ltd (NASDAQ:TLSA) said new biomarker data show its experimental intranasal therapy reduces brain...
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said new biomarker data from an expanded-access program showed its experimental intranasal therapy reduced brain inflammation and was associated with neuroprotective changes in patients with a progressive form of multiple sclerosis. The late-breaking findings were presented by investigators from Brigham and Women's Hospital in a poster detailing results in 10 patients with…
BOSTON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces positive new biomarker data from a late-breaking poster titled “Nasal foralumab downregulates CSF inflammation and upregulates CSF neuroprotective proteomic pathways which correlate with…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for TLSA.
U.S. House Trading
No House trades found for TLSA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.